Sort
48,018 grants matching “immunotherapy”
Population Modeling of Bladder Cancer Detection and Control
$654,490Thomas Trikalinos · Brown University · U01 · FY2022 · CA
Resistance mechanisms to autophagy-modulating therapies
$654,428Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2025 · CA
Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy
$654,412Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2023 · CA
Sex Differences in NK Cells Mediated by X-linked UTX
$654,304Maureen A Su · University Of California Los Angeles · R01 · FY2024 · AI
Sex Differences in NK Cells Mediated by X-linked UTX
$654,304Maureen A Su · University Of California Los Angeles · R01 · FY2025 · AI
Role of mouse microbiome in cancer and inflammation
$654,175Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Regulation of human dendritic cell activation
$654,175Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
$654,143Allison W. Kurian · Stanford University · R01 · FY2025 · CA
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
$654,111Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2022 · CA
Dissecting the role of CD8+ T cells in atherosclerosis
$654,084Chiara Giannarelli · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · HL
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$654,058Robert H Vonderheide · University Of Pennsylvania · P01 · FY2019 · CA
Determinants of differentiation and maintenance of PD-1+ CD8 T cells
$653,982Alice Oliffson Kamphorst · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
$653,885Ming You · Medical College Of Wisconsin · R01 · FY2018 · CA
Functional Microbiomics, Inflammation and Pathogenicity
$653,846Richard J Lamont · University Of Louisville · P20 · FY2023 · GM
Imaging Modulation of Immune Phenotype
$653,804Katherine W Ferrara · Stanford University · R01 · FY2025 · CA
Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancer
$653,786Yanhong Liu · Baylor College Of Medicine · R01 · FY2025 · CA
Causes and Consequences of Adenosine Signaling in Pancreatic Cancer
$653,625Timothy R Donahue · University Of California Los Angeles · R01 · FY2025 · CA
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$653,623Rebecca L Aft · Washington University · R01 · FY2025 · CA
Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies
$653,602Ronald J Falk · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DK
Population Modeling of Bladder Cancer Detection and Control
$653,602Thomas Trikalinos · Brown University · U01 · FY2023 · CA
Mechanisms for initiation of food allergy early in life
$653,596Joan M Cook-Mills · Indiana University Indianapolis · R01 · FY2022 · AI
Characterizing the nuclear pore complex-T cell receptor connection
$653,587Maximiliano A Dangelo · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AI
Characterizing the nuclear pore complex-T cell receptor connection
$653,587Maximiliano A Dangelo · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AI
Characterizing the nuclear pore complex-T cell receptor connection
$653,587Maximiliano A Dangelo · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AI
Characterizing the nuclear pore complex-T cell receptor connection
$653,587Maximiliano A Dangelo · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AI